Liangxian Cao
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 28, 2021
Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.Finith Jernigan, Arthur Branstrom, John D Baird
|Jun 09, 2019
Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal Adenocarcinoma.Jaime A Eberle-Singh, Irina Sagalovskiy, H Carlo Maurer
|Oct 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.Liangxian Cao, Marla Weetall, Christopher Trotta
|Jul 21, 2018
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.Megan Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi
|Dec 20, 2016
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform.Liangxian Cao, Marla Weetall, Jenelle Bombard
Pageof 1
